Cephalon: Difference between revisions
CSV import |
CSV import |
||
| Line 26: | Line 26: | ||
{{Biology-stub}} | {{Biology-stub}} | ||
{{Pharma-stub}} | {{Pharma-stub}} | ||
{{No image}} | |||
Revision as of 12:07, 10 February 2025
Cephalon is a term that can refer to different entities in various fields, including biology and corporate entities. This article will cover the primary meanings and uses of the term "Cephalon."
Biology
In biology, the term "cephalon" is derived from the Greek word "kephalē," meaning "head." It is commonly used to describe the head region of certain arthropods, particularly within the subphylum Trilobita.
Trilobites
Trilobites are an extinct group of marine arthropods that existed during the Paleozoic Era. The cephalon of a trilobite is the anterior part of the body, which includes the glabella, eyes, and mouthparts. The cephalon is typically separated from the thorax and pygidium by distinct sutures.
Corporate Entity
Cephalon, Inc. was a biopharmaceutical company that specialized in the development and commercialization of medications for central nervous system disorders, pain, and cancer. The company was founded in 1987 by Dr. Frank Baldino, Jr. and was headquartered in Frazer, Pennsylvania.
History
Cephalon, Inc. was established with a focus on developing treatments for neurological disorders. Over the years, the company expanded its product portfolio to include medications for pain management and oncology. In 2011, Cephalon was acquired by Teva Pharmaceutical Industries, a global pharmaceutical company.
Products
Some of the notable products developed by Cephalon include:
- Provigil (modafinil) - a medication used to treat narcolepsy and other sleep disorders.
- Fentora (fentanyl buccal tablet) - a pain medication used for breakthrough cancer pain.
- Treanda (bendamustine) - a chemotherapy drug used to treat certain types of cancer.
Related Pages

